Notes - Consolidated Statement Of Comprehensive Income

Fuji Pharma Co.,Ltd. - Filing #7290798

Concept 2023-10-01 to
2024-09-30
2022-10-01 to
2023-09-30
Notes - Consolidated statement of comprehensive income
Notes - Consolidated single statement of comprehensive income
Notes regarding write-downs of inventories
Write-downs of inventories
195,000,000 JPY
-127,000,000 JPY
Research and development expenses included in general and administrative expenses and manufacturing costs for period
Research and development expenses included in general and administrative expenses and manufacturing costs for period
3,401,000,000 JPY
3,184,000,000 JPY
Notes regarding reclassification adjustments and tax effects relating to other comprehensive income

Talk to a Data Expert

Have a question? We'll get back to you promptly.